Fennec Pharmaceuticals Resubmits New Drug Application To U.S. Food And Drug Administration For Pedmark

Research Triangle Park, NC, May 28, 2021– Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a specialty pharmaceutical company, today announced the resubmission of its New Drug Application (NDA) to the U.S. Food and Drug Administration...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news